Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.33 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.32 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.32 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.32 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22830125 | 0.97 | TSHR (0.37) | TSHRALDH1A1LMNABBOX1EHMT2 | |
| Water SCHEMBL9174447 | 0.97 | TSHR (0.37) | TSHRALDH1A1LMNABBOX1EHMT2 | |
| SCHEMBL3482541 | 0.84 | ACHE (0.48) | TSHRALDH1A1LMNATDP1CA1 | |
| SCHEMBL3482115 | 0.80 | ACHE (0.38) | TSHRALDH1A1LMNACYP1A2TDP1 | |
| SCHEMBL203456 | 0.79 | — | — | |
| SCHEMBL3481983 | 0.78 | TP53 (0.54) | TSHRALDH1A1LMNACYP1A2TDP1 | |
| SCHEMBL11293210 | 0.76 | TSHR (0.37) | TSHRALDH1A1LMNABBOX1EHMT2 | |
| SCHEMBL7866284 | 0.75 | LTA4H (0.33) | TSHRTDP1SMN1; SMN2LTA4H | |
| SCHEMBL12272581 | 0.73 | TSHR (0.35) | TSHRALDH1A1LMNABBOX1EHMT2 | |
| SCHEMBL21527935 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117683065-B | Phosphine ligand containing silicon-hydrogen group, preparation method and application thereof | 华东师范大学 | 2026-05-19 | — | — | CN | claimed |
| US-12612422-B2 | Method for making a siloxane-(meth)acrylate macromonomer | DOW SILICONES CORPORATION (US) | 2026-04-28 | — | — | US | claimed |
| US-20250171395-A1 | PROCESS FOR THE PREPARATION OF AMPHETAMINE AND DERIVATIVES THEREOF | GRANULES INDIA LIMITED (IN) | 2025-05-29 | — | — | US | claimed |
| CN-119899077-A | Method for preparing trans-olefin by chromium-catalyzed diene semi-hydrogenation | 四川大学 | 2025-04-29 | — | — | CN | claimed |
| CN-118496709-B | High-adhesion UV ink and preparation method thereof | 深圳永昌和科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-20250011621-A1 | COMPOSITE COATING, PREPARATION METHOD, AND DEVICE | JIANGSU FAVORED NANOTECHNOLOGY CO., LTD. (CN) | 2025-01-09 | — | — | US | claimed |
| CN-119192106-A | Preparation method of (5-fluoro-2, 3-dihydrobenzofuran-4-yl) methylamine hydrochloride | 乐威医药（江苏）股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-115819258-B | Preparation method of sitagliptin intermediate by using catalyst containing phosphine-oxygen double bond | 浙江大学 | 2024-10-18 | — | — | CN | claimed |
| CN-118724786-A | Carboxylic acid succinimidyl ester compound and synthesis method of intermediate thereof | 上海医药工业研究院有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118676342-A | Silicon-carbon negative electrode material for lithium ion battery and preparation method thereof | 泰安市法拉第能源科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-0540580-A1 | POLYMERIC DRUG DELIVERY SYSTEM. | SEARLE & CO (US) | 1993-05-12 | — | — | EP | claimed |
| WO-1992001477-A1 | POLYMERIC DRUG DELIVERY SYSTEM | G.D. SEARLE & CO. (US) | 1992-02-06 | — | — | WO | claimed |
| US-5063103-A | Ring-opening polymerization of norbornenes in mold in presence of glass mat bonded with polyolefins and/or vinylaromatic polymers, metathesis system catalysts and cocatalysts | NIPPON ZEON CO., LTD. (JP) | 1991-11-05 | — | — | US | claimed |
| US-4912242-A | Process for preparing silicon esters | DOW CORNING CORPORATION (US) | 1990-03-27 | — | — | US | claimed |
| EP-0347819-A2 | Reinforced polymeric matrix | NIPPON ZEON CO., LTD. (JP) | 1989-12-27 | — | — | EP | claimed |
| US-4746752-A | QUATERNARY OR TERTIARY AMINE CATALYST | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1988-05-24 | — | — | US | claimed |
| US-4678768-A | POLYMERS OF HIGH STEREOREGULARITY AND BULK DENSITY | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1987-07-07 | — | — | US | claimed |
| US-4587321-A | Polyquaternary polysiloxane polymers | L'OREAL (FR) | 1986-05-06 | — | — | US | claimed |
| US-4567286-A | Preparation of hydrogenated silanes by redistribution of hydrosilanes | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1986-01-28 | — | — | US | claimed |
| US-4085084-A | Silicone resins having good thermal stability | GENERAL ELECTRIC COMPANY (US) | 1978-04-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612422-B2 | Method for making a siloxane-(meth)acrylate macromonomer | STS, MSMO1, ESD | TSHR 1807/4885ALDH1A1 536/4885LMNA 371/4885 |
| US-20250171395-A1 | PROCESS FOR THE PREPARATION OF AMPHETAMINE AND DERIVATIVES THEREOF | COMT, DDT, DBH | TSHR 4247/4885ALDH1A1 329/4885LMNA 4191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.